Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CGON-09
| Cat. No. | CGON-09 |
| Description |
CpG oligodeoxynucleotides (or CpG ODNs) are synthetic oligonucleotides that contain unmethylated CpG motifs. CpG ODN can bind to and activate a Toll-like receptor 9 (TLR9) and leading to strong immunostimulatory effects. So far 3 major classes of CpG ODNs have been identified, based on their structural and biological characteristics, and are designated Type A, Type B, and Type C. Type A ODNs, which feature a central palindromic CpG-containing phosphodiester (PO) structure followed by a phosphorothioate (PS) homopolymeric G-stretch, are robust inducers of interferon-α (IFN-α) production and dendritic cell maturation. Type B ODNs, in contrast, contain a full phosphorothioate backbone with one or more CpG dinucleotides. They strongly activate B cells but stimulate weakly IFN-α secretion. Type C ODNs, combine the properties of both Type A and B, and are characterized by their complete PS backbone and palindromic CpG-containing motifs. Type C ODNs induce strong IFN-α production from pDC and B cell stimulation. ODN 2006 is a type B CpG ODN with a preference for human TLR9. |
| Features |
• Classification: Type B • Product format: Lyophilized product • Sequence: 5'-tcgtcgttttgtcgttttgtcgtt-3' (lower case letters are phosphorothioate) • Specificity: Human, Mouse, Rat |
| Storage | Store lyophilized product at -20°C. Upon reconstitution, aliquots should be stored at -20°C and are stable for 6 months. Avoid repeated freeze-thaw cycles. |
A: ODN 2006 is a type of B-class CpG ODN.
A: ODN 2006 acts on Toll-like receptor 9 (TLR9) and has a preference for human TLR9.
A: Yes, this reagent can stimulate HD11 cells to produce NO2 and IL-6.
A: The coding sequence is: 5'-tcgtcgttttgtcgttttgtcgtt-3'.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
We successfully strongly activated B cells in mice using this reagent.
The ODN 2006 is prepared under strict sterile conditions, and the endotoxin content is very low.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.